ID   SVN_SCYVA               Reviewed;          95 AA.
AC   P86041;
DT   14-OCT-2008, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 1.
DT   25-MAY-2022, entry version 17.
DE   RecName: Full=Scytovirin {ECO:0000303|PubMed:12614152};
DE            Short=SVN {ECO:0000303|PubMed:16647158};
OS   Scytonema varium.
OC   Bacteria; Cyanobacteria; Nostocales; Scytonemataceae; Scytonema.
OX   NCBI_TaxID=423208;
RN   [1] {ECO:0000305}
RP   PROTEIN SEQUENCE, FUNCTION, MASS SPECTROMETRY, AND DISULFIDE BONDS.
RC   STRAIN=HG-24-1 {ECO:0000269|PubMed:12614152};
RX   PubMed=12614152; DOI=10.1021/bi0205698;
RA   Bokesch H.R., O'Keefe B.R., McKee T.C., Pannell L.K., Patterson G.M.L.,
RA   Gardella R.S., Sowder R.C. II, Turpin J., Watson K., Buckheit R.W. Jr.,
RA   Boyd M.R.;
RT   "A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema
RT   varium.";
RL   Biochemistry 42:2578-2584(2003).
RN   [2] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=16647158; DOI=10.1016/j.peptides.2006.03.018;
RA   Xiong C., O'Keefe B.R., Byrd R.A., McMahon J.B.;
RT   "Potent anti-HIV activity of scytovirin domain 1 peptide.";
RL   Peptides 27:1668-1675(2006).
RN   [3] {ECO:0000305}
RP   SYNTHESIS.
RX   PubMed=16289703; DOI=10.1016/j.pep.2005.09.019;
RA   Xiong C., O'Keefe B.R., Botos I., Wlodawer A., McMahon J.B.;
RT   "Overexpression and purification of scytovirin, a potent, novel anti-HIV
RT   protein from the cultured cyanobacterium Scytonema varium.";
RL   Protein Expr. Purif. 46:233-239(2006).
RN   [4] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=17269926; DOI=10.2174/138161207779313650;
RA   Ratner D.M., Seeberger P.H.;
RT   "Carbohydrate microarrays as tools in HIV glycobiology.";
RL   Curr. Pharm. Des. 13:173-183(2007).
RN   [5] {ECO:0000305}
RP   STRUCTURE BY NMR, AND FUNCTION.
RX   PubMed=17434526; DOI=10.1016/j.jmb.2007.03.030;
RA   McFeeters R.L., Xiong C., O'Keefe B.R., Bokesch H.R., McMahon J.B.,
RA   Ratner D.M., Castelli R., Seeberger P.H., Byrd R.A.;
RT   "The novel fold of scytovirin reveals a new twist for antiviral entry
RT   inhibitors.";
RL   J. Mol. Biol. 369:451-461(2007).
RN   [6] {ECO:0000305}
RP   X-RAY CRYSTALLOGRAPHY (1.0 ANGSTROMS), AND DISULFIDE BONDS.
RX   PubMed=17965185; DOI=10.1110/ps.073157507;
RA   Moulaei T., Botos I., Ziolkowska N.E., Bokesch H.R., Krumpe L.R.,
RA   McKee T.C., O'Keefe B.R., Dauter Z., Wlodawer A.;
RT   "Atomic-resolution crystal structure of the antiviral lectin scytovirin.";
RL   Protein Sci. 16:2756-2760(2007).
CC   -!- FUNCTION: Has strong anti-HIV activity against T-tropic strains of HIV-
CC       1 and weaker activity against M-tropic strains of HIV-1. Inhibits HIV-1
CC       fusion and infection of CD4 LTR beta-gal cells in vitro. Inhibits
CC       fusion of HIV infected CEM-SS cells with uninfected CEM-SS cells, and
CC       fusion of HIV-1 Env expressing HL2/3 cells with CD4 LTR beta-gal cells.
CC       Binds to HIV gp120, HIV gp160 and to a lesser extent HIV gp41. Binding
CC       to HIV gp120 is glycosylation dependent. Binds with high specificity to
CC       the tetrasaccharide Man-alpha-1,2-Man-alpha-1,6-Man-alpha-1,6-Man and
CC       also binds the higher-order oligosaccharides oligomannose 8 and
CC       oligomannose 9. Does not bind to monosaccharides, complex or hybrid N-
CC       linked oligosaccharides or chitin. {ECO:0000269|PubMed:12614152,
CC       ECO:0000269|PubMed:16647158, ECO:0000269|PubMed:17269926,
CC       ECO:0000269|PubMed:17434526}.
CC   -!- MASS SPECTROMETRY: Mass=9712.8; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:12614152};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   PDB; 2JMV; NMR; -; A=1-95.
DR   PDB; 2QSK; X-ray; 1.00 A; A=1-95.
DR   PDB; 2QT4; X-ray; 1.30 A; A=1-95.
DR   PDBsum; 2JMV; -.
DR   PDBsum; 2QSK; -.
DR   PDBsum; 2QT4; -.
DR   AlphaFoldDB; P86041; -.
DR   SMR; P86041; -.
DR   UniLectin; P86041; -.
DR   EvolutionaryTrace; P86041; -.
DR   GO; GO:0030247; F:polysaccharide binding; IDA:UniProtKB.
DR   GO; GO:0050688; P:regulation of defense response to virus; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral protein; Direct protein sequencing; Disulfide bond;
KW   Lectin.
FT   CHAIN           1..95
FT                   /note="Scytovirin"
FT                   /id="PRO_0000352757"
FT   REGION          3..41
FT                   /note="SD1"
FT   REGION          51..89
FT                   /note="SD2"
FT   DISULFID        7..55
FT                   /evidence="ECO:0000269|PubMed:12614152,
FT                   ECO:0000269|PubMed:17965185"
FT   DISULFID        20..32
FT                   /evidence="ECO:0000269|PubMed:17965185"
FT   DISULFID        26..38
FT                   /evidence="ECO:0000269|PubMed:17965185"
FT   DISULFID        68..80
FT                   /evidence="ECO:0000269|PubMed:17965185"
FT   DISULFID        74..86
FT                   /evidence="ECO:0000269|PubMed:17965185"
FT   HELIX           10..12
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          14..18
FT                   /evidence="ECO:0007829|PDB:2JMV"
FT   HELIX           23..25
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          36..40
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          44..47
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          50..53
FT                   /evidence="ECO:0007829|PDB:2JMV"
FT   HELIX           58..60
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          61..66
FT                   /evidence="ECO:0007829|PDB:2JMV"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:2QSK"
FT   STRAND          84..88
FT                   /evidence="ECO:0007829|PDB:2QSK"
SQ   SEQUENCE   95 AA;  9722 MW;  E8F34DFB2E7659AC CRC64;
     GSGPTYCWNE ANNPGGPNRC SNNKQCDGAR TCSSSGFCQG TSRKPDPGPK GPTYCWDEAK
     NPGGPNRCSN SKQCDGARTC SSSGFCQGTA GHAAA
//
